A.M. Liberati
- Hepatology top 5%
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 12
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 6
- Acute Myeloid Leukemia Research 3
- Multiple Myeloma Research and Treatments 3
- Rheumatology top 5%
- Eosinophilic Disorders and Syndromes 4
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 7
-
- Peptidase Inhibition and Analysis 4
-
- Histone Deacetylase Inhibitors Research 3
- Co-authors
- Roberto GerliRenato VanacoreF. GrecoFabrizio LombardiniG. LongombardoA. MorettiL La CivitaE Marzo
- Cited by
- HepatologyGeneticsHematology
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
A.M. Liberati
32 papers receiving 577 citations
Peers
Comparison fields: 5 of 54
- Hepatology 181
- Genetics 222
- Hematology 167
- Rheumatology 175
- Pathology and Forensic Medicine 170
Countries citing papers authored by A.M. Liberati
This map shows the geographic impact of A.M. Liberati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Liberati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Liberati more than expected).
Fields of papers citing papers by A.M. Liberati
This network shows the impact of papers produced by A.M. Liberati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Liberati. The network helps show where A.M. Liberati may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A.M. Liberati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (KCYD) IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS: INITIAL RESULTS OF A PHASE 1 STUDY | 2016 | 1 |
| 2 | WEEKLY CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (WKCYD) FOLLOWED BY MAINTENANCE WITH WEEKLY CARFILZOMIB (WK) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) | 2016 | 2 |
| 3 | Efficacy and safety of bortezomib-rituximab (VCR) vs rituximab® in patients (PTS) with relapsed, R-naive/-sensitive follicular lymphoma (FL): outcome according to prior therapy | 2011 | 1 |
| 4 | FCGR3A polymorphism does not significantly affect response and outcome of follicular lymphoma patients treated in the PRIMA study with rituximab and chemotherapy followed by rituximab maintenance or observation | 2011 | 1 |
| 5 | Bendamustine versus chlorambucil in treatment- naive patients with chronic lymphocytic leukemia: Updated results of an international phase III study | 2009 | 1 |
| 6 | 2009 | 49 | |
| 7 | 2002 | 32 | |
| 8 | 1998 | 2 | |
| 9 | 1998 | 16 | |
| 10 | 1995 | 9 | |
| 11 | 1994 | 9 | |
| 12 | 1994 | 18 | |
| 13 | 1993 | 215 | |
| 14 | IL TRATTAMENTO DELLA LEUCEMIA MIELOIDE CRONICA (LMC) CON INTERFERONE ∅-2B (IFN ∅2B) | 1991 | 1 |
| 15 | 1990 | 8 | |
| 16 | 1988 | 16 | |
| 17 | 1988 | 3 | |
| 18 | 1985 | 1 | |
| 19 | 1985 | 1 | |
| 20 | 1982 | 2 |
About A.M. Liberati
A.M. Liberati is a scholar working on Genetics, Hematology and Rheumatology, having authored 32 papers that have together received 606 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (7 papers), Chronic Myeloid Leukemia Treatments (6 papers), Eosinophilic Disorders and Syndromes (4 papers), Peptidase Inhibition and Analysis (4 papers), Acute Myeloid Leukemia Research (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Hepatology (181 citations), Genetics (222 citations) and Hematology (167 citations). A.M. Liberati has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Roberto Gerli, Renato Vanacore, F. Greco, Fabrizio Lombardini, G. Longombardo, A. Moretti, L La Civita, E Marzo, Cássia Ferri and Mario Lazzarino. Their work appears in journals such as Blood, Annals of Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.